Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Li 2006.

Methods Six‐week, (likely) randomised study.
Participants In‐patients with depression according to CCMD‐III criteria.
Interventions Citalopram: 28 participants.
Escitalopram: 28 participants.
Citalopram dose‐range: 20‐40 mg/day.
Escitalopram dose‐range: 10‐20 mg/day.
Outcomes Change in Hamilton Depression Rating Scale 17 Item (HDRS‐17) from baseline to endpoint, number of patients who responded to treatment.
Notes Waiting for translation from Chinese to English (only abstract available in English).